image
Healthcare - Biotechnology - NASDAQ - US
$ 9.98
-6.73 %
$ 378 M
Market Cap
-3.56
P/E
CASH FLOW STATEMENT
-83.5 M OPERATING CASH FLOW
-55.11%
-63.1 M INVESTING CASH FLOW
-1159.32%
138 M FINANCING CASH FLOW
113.19%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Celcuity Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)(90m)(90m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -112 M
Depreciation & Amortization 130 K
Capital Expenditures -250 K
Stock-Based Compensation 6.99 M
Change in Working Capital 18.3 M
Others 16.9 M
Free Cash Flow -83.7 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
OPERATING CASH FLOW
Net Income (111.8) (63.8) (40.4) (29.6) (9.5) (7.4) (7.5) (6.3) (3.3) (2.3)
Depreciation & Amortization 0.1 0.1 0.2 0.3 0.4 0.3 0.2 0.1 73.1 K 58.4 K
Deferred Income Tax 0 0 0 263 (2.5) 0 92.3 K 0 (0.2) 56.5 K
Stock Based Compensation 7.0 4.9 4.6 2.6 1.8 1.0 1.2 0.9 0.2 56.5 K
Other Operating Activities 2.8 1.1 0.8 5.6 2.5 42.9 K 89.3 K 0.4 0.2 56.5 K
Change in Working Capital 18.3 3.9 (1.3) 0.8 0.2 62.2 K 15.9 K (0.1) 0.2 0.2
Cash From Operations (83.5) (53.8) (36.0) (20.3) (7.1) (6.0) (6.1) (4.9) (2.9) (2.0)
INVESTING CASH FLOW
Capital Expenditures (0.2) 97.6 K (0.2) 81.9 K 89.4 K (0.4) (0.6) (0.2) 40.9 K 79 K
Other Items (62.8) (4.9) (143.9) 500 0 8.9 19.7 (28.7) 0 0
Cash From Investing Activities (63.1) (5.0) (144.0) 81.4 K 89.4 K 8.5 19.1 (29.0) 40.9 K 79 K
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 55.1 K 0 0 0
Total Debt Repaid 59.2 2.45 K 19.5 14.3 5.77 K 5.73 K 3.32 K 7.5 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 15.6 50.5 0.3 0.1 39 K 0.3 0.2 (0.9) 0 1.0
Cash From Financing Activities 138.4 64.9 120.3 93.0 0.1 0.3 0.2 30.7 3.7 4.8
CHANGE IN CASH
Net Change In Cash (8.1) 6.1 (59.7) 72.6 (7.1) 2.8 13.3 (3.2) 0.8 2.7
FREE CASH FLOW
Free Cash Flow (83.7) (53.9) (36.2) (20.4) (7.2) (6.4) (6.7) (5.2) (2.9) (2.1)